Abstract: A transistor device includes: a semiconductor substrate having a doping concentration of a first dopant type; a highly doped source region of a second dopant type formed in a first surface of the semiconductor substrate; a first highly doped drain region of the second dopant type formed in the first surface; a gate structure arranged on the first surface and including a gate electrode formed on the first surface; and a first lightly doped region formed in the first surface and extending from the highly doped source region under the gate electrode. A channel region extends between the first lightly doped region and the highly doped drain region. The channel region has an average doping level of the first dopant type of n×10x that varies by less than 0.5×n×10X between the first lightly doped region and the highly doped drain region along the lateral direction parallel to the first surface.

Abstract: A directly-converting X-ray detector includes: a directly-converting sensor material, which is to be maintained at a working temperature, and configured to have a DC voltage applied thereto; a conditioning unit configured to cause a base current to flow through the sensor material; a heating unit for the sensor material, the heating unit configured to be regulated by a regulating unit to maintain the working temperature; and a control device having a plurality of electronics units, which include the regulating unit. When a new configuration and/or a reconfiguration process takes place, the control device is configured to maintain the operation of the conditioning unit, and to interrupt the operation of the heating unit and/or maintain the operation of the heating unit with the control value most recently ascertained in ordinary operation of the regulating unit.

Abstract: A method for manufacturing a micromechanical structure and a micromechanical structure. The method includes: forming a first micromechanical functional layer; forming a plurality of trenches in the first micromechanical functional layer, which include an upper widened area at the upper side of the first micromechanical functional layer and a lower area of essentially constant width; depositing a sealing layer on the upper side of the first micromechanical functional layer to seal the plurality of trenches, a sealing point of the plurality of trenches being formed below the upper side of the first micromechanical functional layer and the first trenches being at least partially filled; thinning back the sealing layer by a predefined thickness; and forming a second micromechanical functional layer above the thinned-back sealing layer.

Abstract: An electronic device is disclosed. The electronic device includes: a first doped region of a first doping type arranged in a first semiconductor layer of a second doping type complementary to the first doping type; an insulation layer formed on top of the first semiconductor layer and adjoining the first doped region; at least two active device regions arranged in a second semiconductor layer formed on top of the insulation layer; and an electrical connection between one of the at least two active device regions and the first doped region. Each of the at least two active device regions is arranged adjacent to the first doped region and separated from the first doped region by the insulation layer.

Abstract: A directly-converting X-ray detector includes: a directly-converting sensor material, which is to be maintained at a working temperature, and configured to have a DC voltage applied thereto; a conditioning unit configured to cause a base current to flow through the sensor material; a heating unit for the sensor material, the heating unit configured to be regulated by a regulating unit to maintain the working temperature; and a control device having a plurality of electronics units, which include the regulating unit. When a new configuration and/or a reconfiguration process takes place, the control device is configured to maintain the operation of the conditioning unit, and to interrupt the operation of the heating unit and/or maintain the operation of the heating unit with the control value most recently ascertained in ordinary operation of the regulating unit.

Abstract: In an example embodiment a data transmission device for transmitting data packets comprises at least one receive interface configured to receive data packets from a respective data source; a respective receive buffer configured to buffer the data packets received via the respective receive interface; a transfer device configured to transfer the data packets from the respective receive buffer to a transmit buffer, the transmit buffer selected for the respective data packet from a plurality of existing transmit buffers; and a respective transmit interface configured to transmit the data packets stored in the respective transmit buffer to a receiving device, wherein the transfer device is configured to transfer the respective data packet from the respective receive buffer into the selected transmit buffer only when an enable condition exists, the enable condition being based on a fill level of one of the transmit buffers other than the selected transmit buffer.

Abstract: A strain relief facility for a coaxial cable that is connectable to an electronics unit via an associated plug, includes two half-shells forming a receiver for the coaxial cable and the associated plug, and a fastening facility to fasten the strain relief facility to the electronics unit, and to fasten the half-shells to one another. The receiver has at least one cable section to receive the coaxial cable and a plug section to receive the plug.

Abstract: A method includes moving one or more transmit facility or transmit facilities attached to a first component with regard to at least two receive facilities attached at a fixed position to the second component; and at least one of registering a respective error if an error condition exists for the respective receive facility or modifying an operation of an apparatus comprising the first and a second component if the error condition exists for the respective receive facility, the error condition for the respective receive facility depends on location information relating to at least one of the position of the first component with regard to the second component or orientation of the first component with regard to the second component, and/or at least one of a measure for a receive quality of the signals or data packets received from the transmit facility or from at least one of the transmit facilities.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.